GNOM

Global X Genomics & Biotechnology ETF [GNOM] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

GNOM Stock Summary

Top 10 Correlated ETFs

GNOM

Top 10 Correlated Stocks

GNOM

In the News

GNOM Financial details

Company Rating
-
Market Cap
100.61M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-0.81%
SMA50
-8.57%
SMA100
-12.41%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.63-13.33
52W High
-24.38%
52W Low
+22.88%
RSI
46.92
Rel Volume
1.24
Avg Volume
73.96K
Volume
91.98K
Perf Week
3.91%
Perf Month
-3.44%
Perf Quarter
-13.77%
Perf Half Y
-15.62%
-
-
-
-
Beta
1.19
-
-
Volatility
0.19%, 0.24%
Prev Close
-2.09%
Price
9.83
Change
-3.44%

Something similar

Top by Market Cap
0YXG.L
ABEC.DE
META
VTSAX
TL0.DE
Top Correlated ETFs
WDNA
FBT
LABU
HELX
HTEC
Top Correlated Stocks
NPCE
XRAY
ABCL
LINK
ALLY
Similar Market Cap
CNYA
HWO.TO
NODL.OL
SYRS
0508.HK

Company Profile

Financial Services Asset Management - Global
  • Volume Average 73.96K
  • Market Capitalization 100.61M
  • Headquarters US
  • IPO Date 2019-04-10

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.